1. Home
  2. FLY vs GKOS Comparison

FLY vs GKOS Comparison

Compare FLY & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLY

Firefly Aerospace Inc.

HOLD

Current Price

$26.17

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$180.05

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
GKOS
Founded
2017
1998
Country
United States
United States
Employees
1409
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
9.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FLY
GKOS
Price
$26.17
$180.05
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$38.88
$126.92
AVG Volume (30 Days)
3.2M
824.9K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$174.79
$23.32
Revenue Next Year
$66.73
$27.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.33
52 Week Low
$16.00
$73.16
52 Week High
$62.17
$184.00

Technical Indicators

Market Signals
Indicator
FLY
GKOS
Relative Strength Index (RSI) 52.24 73.86
Support Level $23.89 $98.22
Resistance Level $24.35 $184.00
Average True Range (ATR) 1.66 7.05
MACD 0.97 0.87
Stochastic Oscillator 90.07 65.96

Price Performance

Historical Comparison
FLY
GKOS

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: